SCHEMBL5172907

SCHEMBL5172907

CCC1(CC(O)(C=Nc2cccc3cnncc23)C(F)(F)F)CCOc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 8/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5175566 0.90 NR3C1 (0.34) NR3C1
SCHEMBL5173629 0.86 NR3C1 (0.45) NR3C1
SCHEMBL5173632 0.86 NR3C1 (0.45) NR3C1
SCHEMBL5479422 0.84 NR3C1 (0.42) NR3C1
SCHEMBL5479419 0.84 NR3C1 (0.42) NR3C1
SCHEMBL5476388 0.82 NR3C1 (0.43) NR3C1
SCHEMBL5476392 0.82 NR3C1 (0.43) NR3C1
SCHEMBL5174939 0.77 NR3C1 (0.57) NR3C1
SCHEMBL5474798 0.76 NR3C1 (0.48) NR3C1
SCHEMBL5479150 0.76 NR3C1 (0.46) NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869013-A1 SUBSTITUTED CHROMAN DERIVATIVES, METHOD FOR THE PRODUCTION AND THE USE THEREOF IN THE FORM OF ANTIPHLOGISTICS Bayer Schering Pharma Aktiengesellschaft (DE) 2007-12-26 EP disclosed
WO-2006108711-A1 SUBSTITUTED CHROMAN DERIVATIVES, METHOD FOR THE PRODUCTION AND THE USE THEREOF IN THE FORM OF ANTIPHLOGISTICS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-10-19 WO disclosed